ReviewCurrent treatment options in oncology2021

Insights into the Use of Peripherally Acting μ-Opioid Receptor Antagonists (PAMORAs) in Oncologic Patients: from Scientific Evidence to Real Clinical Practice.

Ana Fernández-Montes et al.PubMed ↗Publisher ↗

No numbers read from the abstract.